You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.

Xpert Xpress SARS-CoV-2 Test

Our Mission

Delivering A Better Way to improve patient outcomes by enabling access to molecular diagnostic
testing everywhere.

Our Vision

To be the leading provider of seamlessly connected diagnostic solutions.

 

#timeline-content-3 .stopwatch path { --progress: ${progressBar}$; }

A Track Record of Innovation

System

2000

SmartCycler
Integrated amplification and detection.

2006

GeneXpert System
Integrated sample preparation, amplification, and detection. Available in 1-, 4-, and 16-module configurations.

 

2009

Infinity-48 System
Even greater automation than GeneXpert, with up to 48 modules

 

2011

Infinity-80 System
With up to 80 modules

 

2017

GeneXpert Xpress
System for near patient applications launched with Xpert® Xpress Flu and Xpert Xpress Flu/RSV.

 

2019

GeneXpert Omni
Portable single module launched into the Emerging Markets.

For In Vitro Diagnostic Use.

#timeline-content-5 .stopwatch path { --progress: ${progressBar}$; }

Milestone Test Introductions

2004

Anthrax Cartridge
Integrated sample preparation, amplification, and detection for deployment in US Postal Service sorting offices.

2006

First Clinical Xpert Test
Xpert GBS was the first clinical test launched for the GeneXpert System

2010

HBDC Program WHO endorsement of Xpert MTB/RIF.

2013

Xpert CT/NG
Launched in the US, making Cepheid's initial entry into high volume testing markets.

2017

Xpress
Results in 30 minutes or less.

 

 

 

 

Oncology
Entry into Oncology with the STRAT4 Breast Cancer test.

 

 

 

2018

Xpert HCV VL Fingerstick
First molecular test to detect HCV RNA levels directly from a fingerstick of blood.

 

 

 

For In Vitro Diagnostic Use.

Back to Top